Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2021-02-01 4:33 pm Sale | 13G | SORRENTO THERAPEUTICS, INC. SRNE | Top Path Asia Ltd | 0 0% | -6,831,955 (Position Closed) | View |
| 2021-02-01 4:33 pm Sale | 13G | SORRENTO THERAPEUTICS, INC. SRNE | Hongguo International Holdings Ltd | 4,074,000 1.5% | -2,757,955 (-40.37%) | View |
| 2021-02-01 4:32 pm Sale | 13G | SORRENTO THERAPEUTICS, INC. SRNE | China In Shine Investment Ltd | 4,760,801 1.8% | -7,239,458 (-60.33%) | View |
| 2020-04-09 5:15 pm Purchase | 13G | SORRENTO THERAPEUTICS, INC. SRNE | BlackRock Inc. BLK | 8,790,097 4.8% | 147,039 (+1.70%) | View |
| 2020-02-14 06:05 am Sale | 13G | SORRENTO THERAPEUTICS, INC. SRNE | Ally Bridge Group Capital Partners II L.P. | 4,910,374 2.9% | -2,733,933 (-35.76%) | View |
| 2020-02-10 4:48 pm Purchase | 13G | SORRENTO THERAPEUTICS, INC. SRNE | Asia Pacific MedTech (BVI) Ltd | 15,317,632 9.1% | 4,299,645 (+39.02%) | View |
| 2020-02-10 4:46 pm Purchase | 13G | SORRENTO THERAPEUTICS, INC. SRNE | Famous Sino Ltd | 10,590,722 6.2% | 2,558,767 (+31.86%) | View |
| 2020-02-10 4:45 pm Purchase | 13G | SORRENTO THERAPEUTICS, INC. SRNE | China In Shine Investment Ltd | 12,000,259 7% | 3,518,304 (+41.48%) | View |
| 2020-02-06 09:09 am Purchase | 13G | SORRENTO THERAPEUTICS, INC. SRNE | BlackRock Inc. BLK | 8,643,058 6.1% | 1,076,820 (+14.23%) | View |
| 2019-09-25 5:31 pm Purchase | 13G | SORRENTO THERAPEUTICS, INC. SRNE | OAKTREE CAPITAL MANAGEMENT LP | 7,622,289 5.5% | 7,622,289 (New Position) | View |
| 2019-05-09 5:14 pm Unchanged | 13D | SORRENTO THERAPEUTICS, INC. SRNE | OPKO HEALTH INC. OPK | 0 0% | 0 (Unchanged) | View |